Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. May 15, 2023; 15(5): 859-877
Published online May 15, 2023. doi: 10.4251/wjgo.v15.i5.859
Published online May 15, 2023. doi: 10.4251/wjgo.v15.i5.859
Figure 4 Tumor-free survival rate.
A: Tumor-free survival rate after liver resection in patients with hepatocellular carcinoma with and without guideline compliance (P < 0.001); B: Tumor-free survival rate after liver resection among patients with different China Liver Cancer staging levels. Early stage vs middle stage, P < 0.001; early stage vs late stage, P < 0.001; middle stage vs late stage, P = 0.099.
- Citation: Yan YW, Liu XK, Zhang SX, Tian QF. Real-world 10-year retrospective study of the guidelines for diagnosis and treatment of primary liver cancer in China. World J Gastrointest Oncol 2023; 15(5): 859-877
- URL: https://www.wjgnet.com/1948-5204/full/v15/i5/859.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i5.859